DHR Congressional Stock Trades
DANAHER CORPORATION CMN
Last disclosed trade Jun 16
Every disclosed trade in DHR by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Coldpine’s read
Sessions sits on Financial Services but holds no direct healthcare or life-sciences oversight that would tie him to Danaher's diagnostics and biotech instrumentation business. The 9-day disclosure lag is relatively prompt, making this spouse-held sale recent enough to remain actionable. One other member sold DHR in the same direction within 30 days, a modest cluster worth noting.
Pete Sessions · Sold · Jun 12
Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →
Follow $DHR
Get notified when any member of Congress trades $DHR. Free, no card, no spam.
Members who trade DHR
Recent disclosed trades in DHR
| Date | Member | Type | Amount |
|---|---|---|---|
| Jun 16 | Rohit Khanna(CA) | buy | $1K–$15K |
| Jun 2 | Rohit Khanna(CA) | buy | $15K–$50K |
| May 22 | Michael T. McCaul(TX) | buy | $1K–$15K |
| May 14 | Michael T. McCaul(TX) | buy | $1K–$15K |
| May 4 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Apr 28 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Apr 24 | Rohit Khanna(CA) | buy | $1K–$15K |
| Apr 13 | Rohit Khanna(CA) | buy | $1K–$15K |
| Mar 5 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Nov 7 | Rohit Khanna(CA) | sell | $15K–$50K |
| Nov 3 | Rohit Khanna(CA) | buy | $1K–$15K |
| Oct 27 | Michael T. McCaul(TX) | sell | $15K–$50K |
| Oct 7 | Julie Johnson(TX) | buy | $1K–$15K |
| Oct 3 | Rohit Khanna(CA) | buy | $1K–$15K |
| Sep 25 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Sep 25 | Lisa McClain(MI) | sell | $1K–$15K |
| Sep 12 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Sep 9 | Michael T. McCaul(TX) | buy | $1K–$15K |
| Sep 5 | Rohit Khanna(CA) | sell | $1K–$15K |
| Sep 3 | Thomas H. Kean(NJ) | buy | $1K–$15K |
Showing 20 of 75 disclosed trades.
Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.
Create a free accountData sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →